Mistletoe Clinical Trial - Now Open
To learn more about who is eligible to participate, please visit the Johns Hopkins SKCCC Clinical Trials website or email firstname.lastname@example.org.
Believe Big is excited to be in the trenches with cancer research. We are supporting Johns Hopkins University School of Medicine to develop the first clinical trial in the United States using intravenous Mistletoe. This clinical trial brings together the conventional and complementary medical communities to fight cancer.
Mistletoe treatment for cancer is used widely in Germany and Switzerland, but in the United States, every potential treatment must be studied in a series of steps, called phases. Each phase is designed to answer a separate research question. The Mistletoe clinical trial at Johns Hopkins will be a Phase 1 trial, in which researchers will be testing the drug on a small group of participants to evaluate safety, determine a safe dose, and identify side effects. This is the first step of many research steps before mistletoe can be considered for conventional use in cancer treatment.
Due to the high level of interest in the study, we are assessing eligibility for the study in advance of a visit to Johns Hopkins. If you think you are eligible, please provide a copy of your most recent oncologist’s note, lab work, and imaging results. Please email documents to: email@example.com or call 410-502-5140 for mailing address.
To find out more about Mistletoe in science and medicine click here.
FDA Required Disclaimer For Sites That Do Not Endorse Chemotherapy:
This web site is for educational purposes only. It is not intended as a substitute for the diagnosis, treatment and advice of a qualified licensed professional. This site offers people medical information and tells them their alternative medical options, but in no way should anyone consider that this site represents the “practice of medicine.” This site assumes no responsibility for how this material is used. Also note that this website frequently updates its contents, due to a variety of reasons, therefore, some information may be out of date. The statements regarding alternative treatments for cancer have not been evaluated by the FDA